دارویی ره آورد تامین
درهآور | Stocks - Iran Fara Bourse (IFB)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 14,040 2.77
Close Price: 14,010
Cash Flow
AGM
Interim
2026/05/26 Fiscal Year 2026/03/2012 Month / Audited | 2026/05/17 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 1.607 Trillion | 1.607 Trillion | |
Income Taxes Paid | -252.641 Billion | -252.64 Billion | |
Net Cash Flow from Operating Activities | 1.354 Trillion | 1.354 Trillion | |
Proceeds from Sale of Property, Plant and Equipment | 7.41 Billion | 7.41 Billion | |
Purchases of Property, Plant and Equipment | -1.001 Trillion | -1.001 Trillion | |
Purchases of Intangible Assets | -47.676 Billion | -47.675 Billion | |
Cash Paid to Acquire Long-Term Investments | -8 Million | -8 Million | |
Proceeds from Sale of Short-Term Investments | 439 Million | 439 Million | |
Dividends Received | 5.33 Billion | 5.33 Billion | |
Cash Received from Income on Other Investments | 2.413 Billion | 2.413 Billion | |
Net Cash Flow from Investing Activities | -1.033 Trillion | -1.033 Trillion | |
Net Cash Flow before Financing Activities | 321.307 Billion | 321.308 Billion | |
Proceeds from Sale of Treasury Shares | 120.702 Billion | 120.702 Billion | |
Purchases of Treasury Shares | -142.162 Billion | -142.162 Billion | |
Cash Received from Borrowings | 8.943 Trillion | 8.943 Trillion | |
Repayments of Borrowings (Principal) | -6.79 Trillion | -6.79 Trillion | |
Interest Paid on Borrowings | -837.136 Billion | -837.137 Billion | |
Dividends Paid | -1.357 Trillion | -1.357 Trillion | |
Net Cash Flow from Financing Activities | -62.601 Billion | -62.602 Billion | |
Net Increase (Decrease) in Cash | 258.706 Billion | 258.706 Billion | |
Cash at Beginning of Period | 1.454 Trillion | 1.454 Trillion | |
Effect of Exchange Rate Changes | 37.42 Billion | 37.42 Billion | |
Cash at End of Period | 1.491 Trillion | 1.491 Trillion |